Updates in Pediatric Endocrinology and Diabetes in 2018

Kaitlyn Shank¹, B.S. & Kanika Shanker^1,2*, M.B.B.S., M.D.

¹Penn State College of Medicine, Penn State Health, Milton S. Hershey Medical Center, Hershey, Pennsylvania
²Clinical Assistant Professor of Pediatrics, Summit Endocrinology, Summit Physician Services, Summit Health, Chambersburg

Dr. Kanika Shanker, Clinical Assistant Professor of Pediatrics, Summit Health, USA.

Keywords: Updates; Diabetes; Endocrinology; Insulin; FDA

Abstract

Pediatric endocrinology deals largely with the very common diseases of childhood and adolescence such as diabetes, rickets and obesity along with more rare and nuanced diseases such as congenital adrenal hyperplasia and disorders of sexual differentiation. Technology rapidly advances the treatment of diabetes and guidelines are constantly changing for the treatment of many common endocrine conditions. In this succinct review, we present the most updated recommendations and guidelines provided by the nationally and internationally recognized regulatory bodies such as The Endocrine Society, The Pediatric Endocrine Society and the USA Food and Drug Administration. Through this mini review, we hope to provide important updates and knowledge to the providers taking care of neonates, young children and adolescents worldwide.

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).